What is the management for constipation in a patient with Organophosphate (OP) poisoning on atropine who has not passed stool for 6 days?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Constipation in a Patient with Organophosphate Poisoning on Atropine

For a patient with organophosphate poisoning on atropine therapy who has not passed stool for 6 days, aggressive management with stimulant laxatives and osmotic agents is recommended to prevent complications of severe constipation. 1

Assessment and Initial Management

  • Rule out intestinal obstruction through physical examination and abdominal x-ray before initiating treatment 1
  • Consider paralytic ileus as a potential complication of prolonged atropine therapy in organophosphate poisoning 2
  • Evaluate for other causes of constipation such as electrolyte abnormalities (hypercalcemia, hypokalemia) that may be contributing 1

First-Line Treatment

  • Start with stimulant laxatives: bisacodyl 10-15 mg daily to TID with a goal of achieving one non-forced bowel movement every 1-2 days 1, 3
  • Add osmotic laxatives such as polyethylene glycol (1 capful/8 oz water BID) 1
  • Ensure adequate hydration to improve efficacy of laxatives 1, 3

If Initial Treatment Fails

  • Administer glycerine suppository with or without mineral oil retention enema 1
  • Consider adding other laxative agents:
    • Bisacodyl suppository (one rectally daily-BID) 1
    • Lactulose 30-60 mL BID-QID 1
    • Sorbitol 30 mL every 2 hours × 3, then as needed 1
    • Magnesium hydroxide 30-60 mL daily-BID 1
    • Magnesium citrate 8 oz daily 1

For Severe or Refractory Constipation

  • Perform manual disimpaction if needed, with pre-medication using analgesics and/or anxiolytics 1
  • Consider adding a prokinetic agent such as metoclopramide 10-20 mg PO QID 1, 3
  • For severe cases, methylnaltrexone 0.15 mg/kg subcutaneously every other day (not more than once daily) may be considered 1
  • Administer tap water enema until clear if other measures fail 1

Special Considerations for Atropine-Induced Constipation

  • Atropine therapy for organophosphate poisoning can cause severe anticholinergic effects including paralytic ileus 2
  • Patients on high-dose atropine therapy (as often required in organophosphate poisoning) are at particularly high risk for severe constipation 4
  • Monitor for signs of developing paralytic ileus, which may indicate recovery from organophosphate poisoning as cholinesterase levels increase 2

Monitoring and Follow-up

  • Reassess for cause and severity of constipation if initial treatments fail 1
  • Recheck for impaction or obstruction if symptoms persist 1
  • Monitor for signs of bacterial overgrowth which may develop in motionless dilated loops of bowel 1
  • Evaluate for possible small intestinal bacterial overgrowth (SIBO) if constipation persists despite treatment 1

Prevention of Complications

  • Aim for regular bowel movements (every 1-2 days) to prevent severe complications 3
  • Avoid using stool softeners alone without stimulant laxatives, as this is ineffective for severe constipation 3
  • Consider early aggressive intervention to prevent progression to more serious complications such as bowel obstruction 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Clozapine-Associated Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.